FIELD: pharmacy.
SUBSTANCE: agent comprises a Na-salt of chondroitin sulfate having an intrinsic viscosity (η), which is equal to 0.01-0.05 m3/kg, in the amount of 4-12 wt %, benzyl alcohol as a preservative in the amount of 0.8-1.2 wt % and water in the remaining amount. The agent may additionally comprise a stabilizer - sodium bisulfite in the amount of 0.09-0.11 wt %.
EFFECT: desired therapeutic effect in the absence of side effects such as pain at the time of injection and appearance of induration at injection sites.
4 cl, 2 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL PREPARATION FOR TREATMENT OF ARTHROLOGICAL DISEASES | 2015 |
|
RU2743274C2 |
| METHOD OF PREPARING INJECTION FORM OF CHONDROITIN SULPHATE | 2015 |
|
RU2580589C1 |
| PHARMACEUTICAL AGENT FOR ARTHRITIC DISEASES TREATMENT | 2020 |
|
RU2739747C1 |
| PRODUCTION METHOD OF PREPARATION INJECTABLE FORM BASED ON SULFATE CHONDROITIN | 2015 |
|
RU2612019C1 |
| PHARMACEUTICAL AGENT FOR ARTHRITIC DISEASES TREATMENT | 2020 |
|
RU2739746C1 |
| PHARMACEUTICAL AGENT FOR ARTHRITIC DISEASES TREATMENT | 2020 |
|
RU2739184C1 |
| CHONDROITIN SULFATE SOLUTION FOR INTRAMUSCULAR ADMINISTRATION AND METHOD FOR ITS PREPARATION | 2015 |
|
RU2623050C2 |
| PHARMACEUTICAL AGENT FOR TREATING ARTHROLOGICAL DISEASES | 2023 |
|
RU2813891C1 |
| METHOD OF PREPARING INJECTION FORM OF CHONDROITIN SULFATE | 2015 |
|
RU2677330C2 |
| AGENT FOR ARTHROLOGICAL DISEASES TREATMENT | 1992 |
|
RU2021812C1 |
